SPOK
Neutral signalScored 2026-08-13 Drivers: fundamentals. Moteurs : fondamentaux.
Research, not advice.
À propos
Spok Holdings, Inc.
- Nom
- Spok Holdings, Inc.
- Secteur
- Healthcare
- Industrie
- Medical - Healthcare Information Services
- Bourse
- NASDAQ
- Capitalisation
- $215.1M
- Employés
- 382
- PDG
- Vincent D. Kelly
- Site web
- https://www.spok.com
- Marché
- CERSCGCDHMASSNRCSENS
Spok Holdings, Inc., operating primarily through its subsidiary, Spok, Inc., specializes in providing advanced communication solutions tailored for the healthcare sector. These crucial services span a wide international footprint, covering the United States, Europe, Canada, Australia, Asia, and the Middle East. The company's core mission is to elevate patient outcomes by meticulously delivering critical clinical information to care teams precisely when and where it holds the most significance. Spok's service portfolio includes subscription options for both one-way and two-way messaging, alongside supplementary offerings such as voicemail functionalities and protective plans for equipment. The company also acts as a supplier of communication devices to resellers, who subsequently lease or resell these units to their own customers. A flagship offering is the Spok Care Connect platform, an integrated system engineered to streamline clinician workflows and bolster administrative compliance. In addition to its primary solutions, Spok provides professional services, regular software license updates, and comprehensive product support. It also facilitates the sale of third-party equipment. Its diverse clientele extends beyond healthcare providers to include various businesses, management personnel, field sales and service teams, members of the construction and real estate industries, manufacturing organizations, and government entities. Founded in 1986 and headquartered in Alexandria, Virginia, the company rebranded as Spok Holdings, Inc. in July 2014, having previously operated as USA Mobility, Inc.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 8 320 titres (~93 869,57 $ US)
- Insiders
- COURNOYER CHRISTINE
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$225,940
Avg sell (VWAP, 90d window) $11.30 vs last close —
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
- Last activity
- 2026-08-10
- Last synced
-
2026-08-16 09:56:14
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-08-10 | COURNOYER CHRISTINE | Sell · S | 0 | $0.00 | $0 | Form 4 |
| 2026-08-10 | Woods-Keisling Sharon | Sell · S | 20,000 | $11.30 | $225,940 | Form 4 |
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Neutral signalScored 2026-08-13 Drivers: fundamentals. Moteurs : fondamentaux.
SPOK shows solid financial foundations — minimal debt, strong cash flow, and improving margins — paired with a genuine earnings catalyst (Q2 2026 beat, record adjusted EBITDA, hospital recognition), but the catalyst…
The first sentence of the analysis written for SPOK on 2026-08-13 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Timing Unavailable or mixed. No stored price series
- Financial indicators Supports a bullish reading. Current ratio 1.18 · operating margin 14%
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 78.8% | 79.3% | 58.9% | 56.0% | 49.2% | |
| Ebit Margin | 15.3% | 14.6% | 16.1% | 0.7% | -19.2% | |
| Ebitda Margin | 17.8% | 17.6% | 19.3% | 3.4% | -11.9% | |
| Operating Profit Margin | 14.1% | 13.8% | 15.7% | 5.6% | -8.5% | |
| Pretax Profit Margin | 15.3% | 14.6% | 16.1% | 0.7% | -19.2% | |
| Continuous Operations Profit Margin | 11.4% | 10.9% | 11.3% | 16.2% | -15.6% | |
| Net Profit Margin | 11.4% | 10.9% | 11.3% | 16.2% | -15.6% | |
| Bottom Line Profit Margin | 11.4% | 10.9% | 11.3% | 16.2% | -15.6% | |
| Current Ratio | 1.179 | 1.257 | 1.331 | 1.311 | 1.710 | |
| Quick Ratio | 1.179 | 1.257 | 1.331 | 1.182 | 1.589 | |
| Solvency Ratio | 0.323 | 0.307 | 0.315 | 0.351 | -0.158 | |
| Cash Ratio | 0.515 | 0.598 | 0.666 | 0.669 | 0.811 | |
| Price To Earnings Ratio | 17.130 | 21.689 | 19.595 | 7.378 | -8.184 | |
| Price To Earnings Growth Ratio | 4.225 | -3.427 | -0.680 | -0.037 | 0.161 | |
| Forward Price To Earnings Growth Ratio | 4.225 | -3.427 | -0.680 | -0.037 | 0.161 | |
| Price To Earnings Diluted Ratio | 17.587 | 21.986 | 20.104 | 7.514 | -8.184 | |
| Price To Earnings Diluted Growth Ratio | 6.419 | -4.232 | -0.685 | -0.038 | 0.161 | |
| Price To Book Ratio | 1.857 | 2.099 | 1.886 | 0.936 | 1.042 | |
| Price To Sales Ratio | 1.945 | 2.360 | 2.222 | 1.198 | 1.274 | |
| Price To Free Cash Flow Ratio | 10.787 | 12.634 | 13.567 | 60.118 | -24.913 | |
| Price To Operating Cash Flow Ratio | 9.389 | 11.233 | 11.797 | 24.956 | 22.721 | |
| Debt To Assets Ratio | 0.034 | 0.040 | 0.049 | 0.064 | 0.070 | |
| Debt To Equity Ratio | 0.047 | 0.057 | 0.068 | 0.091 | 0.100 | |
| Debt To Capital Ratio | 0.045 | 0.054 | 0.063 | 0.084 | 0.091 | |
| Long Term Debt To Capital Ratio | 0.028 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.408 | 1.403 | 1.390 | 1.421 | 1.429 | |
| Working Capital Turnover Ratio | 13.119 | 9.691 | 8.560 | 4.835 | 2.829 | |
| Operating Cash Flow Ratio | 0.589 | 0.593 | 0.545 | 0.121 | 0.145 | |
| Operating Cash Flow Sales Ratio | 0.207 | 0.210 | 0.188 | 0.048 | 0.056 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.870 | 0.889 | 0.870 | 0.415 | -0.912 | |
| Debt Service Coverage Ratio | 7.216 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 10.818 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 4.172 | 3.297 | 2.362 | 0.411 | 0.461 | |
| Capital Expenditure Coverage Ratio | 7.714 | 9.013 | 7.663 | 1.710 | 0.523 | |
| Dividend Paid And Capex Coverage Ratio | 0.933 | 0.977 | 0.901 | 0.224 | 0.315 | |
| Dividend Payout Ratio | 1.716 | 1.763 | 1.637 | 1.144 | -0.452 | |
| Enterprise Value Multiple | 10.191 | 12.574 | 10.737 | 30.881 | -9.105 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 78.8% | ▼-0.5% | ▲14.4% |
| Ebit Margin | 15.3% | ▲0.8% | ▲9.8% |
| Ebitda Margin | 17.8% | ▲0.2% | ▲8.6% |
| Operating Profit Margin | 14.1% | ▲0.3% | ▲6.0% |
| Pretax Profit Margin | 15.3% | ▲0.8% | ▲9.8% |
| Continuous Operations Profit Margin | 11.4% | ▲0.5% | ▲4.5% |
| Net Profit Margin | 11.4% | ▲0.5% | ▲4.5% |
| Bottom Line Profit Margin | 11.4% | ▲0.5% | ▲4.5% |
| Current Ratio | 1.179 | ▼-0.078 | ▼-0.179 |
| Quick Ratio | 1.179 | ▼-0.078 | ▼-0.129 |
| Solvency Ratio | 0.323 | ▲0.017 | ▲0.096 |
| Cash Ratio | 0.515 | ▼-0.083 | ▼-0.137 |
| Price To Earnings Ratio | 17.130 | ▼-4.559 | ▲5.608 |
| Price To Earnings Growth Ratio | 4.225 | ▲7.652 | ▲4.177 |
| Forward Price To Earnings Growth Ratio | 4.225 | ▲7.652 | ▲4.177 |
| Price To Earnings Diluted Ratio | 17.587 | ▼-4.400 | ▲5.785 |
| Price To Earnings Diluted Growth Ratio | 6.419 | ▲10.652 | ▲6.094 |
| Price To Book Ratio | 1.857 | ▼-0.243 | ▲0.293 |
| Price To Sales Ratio | 1.946 | ▼-0.415 | ▲0.146 |
| Price To Free Cash Flow Ratio | 10.787 | ▼-1.847 | ▼-3.651 |
| Price To Operating Cash Flow Ratio | 9.389 | ▼-1.844 | ▼-6.630 |
| Debt To Assets Ratio | 0.034 | ▼-0.007 | ▼-0.018 |
| Debt To Equity Ratio | 0.047 | ▼-0.009 | ▼-0.025 |
| Debt To Capital Ratio | 0.045 | ▼-0.008 | ▼-0.022 |
| Long Term Debt To Capital Ratio | 0.028 | ▲0.028 | ▲0.023 |
| Financial Leverage Ratio | 1.408 | ▲0.005 | ▼-0.002 |
| Working Capital Turnover Ratio | 13.119 | ▲3.428 | ▲5.313 |
| Operating Cash Flow Ratio | 0.590 | ▼-0.004 | ▲0.191 |
| Operating Cash Flow Sales Ratio | 0.207 | ▼-0.003 | ▲0.065 |
| Free Cash Flow Operating Cash Flow Ratio | 0.870 | ▼-0.019 | ▲0.444 |
| Debt Service Coverage Ratio | 7.216 | ▲7.216 | ▲5.773 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 10.818 | ▲10.818 | ▲8.654 |
| Operating Cash Flow Coverage Ratio | 4.172 | ▲0.875 | ▲2.031 |
| Capital Expenditure Coverage Ratio | 7.714 | ▼-1.299 | ▲2.389 |
| Dividend Paid And Capex Coverage Ratio | 0.933 | ▼-0.044 | ▲0.263 |
| Dividend Payout Ratio | 1.716 | ▼-0.046 | ▲0.555 |
| Enterprise Value Multiple | 10.191 | ▼-2.383 | ▼-0.865 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $271.8M | $324.9M | $308.9M | $161.1M | $181.0M | |
| Enterprise value | $253.5M | $304.5M | $288.0M | $141.1M | $153.7M | |
| EV / Sales | 1.81x | 2.21x | 2.07x | 1.05x | 1.08x | |
| EV / Op. cash flow | 8.76x | 10.53x | 11.00x | 21.85x | 19.30x | |
| EV / Free cash flow | 10.06x | 11.84x | 12.65x | 52.64x | -21.16x | |
| EV / EBITDA | 10.19x | 12.57x | 10.74x | 30.88x | -9.11x | |
| Net debt / EBITDA | -0.74x | -0.84x | -0.78x | -4.39x | 1.62x | |
| Current ratio | 1.18x | 1.26x | 1.33x | 1.31x | 1.71x | |
| Income quality | 1.82x | 1.93x | 1.67x | 0.29x | -0.36x | |
| Graham number | $11 | $11 | $12 | $15 | — | |
| Graham net-net | -$1 | -$1 | -$1 | -$1 | $0 | |
| Tax burden | 74.1% | 74.7% | 70.2% | 2192.2% | 81.2% | |
| Interest burden | 100.0% | 99.8% | 100.0% | 100.0% | 100.0% | |
| Working capital | $8.8M | $12.5M | $15.9M | $16.6M | $39.1M | |
| Invested capital | $120.2M | $125.9M | $132.9M | $137.9M | $160.8M | |
| Return on assets | 7.7% | 6.9% | 6.9% | 8.9% | -8.9% | |
| Operating ROA | 9.3% | 8.5% | 9.2% | 3.1% | -4.6% | |
| Return on tangible assets | 14.9% | 12.7% | 12.2% | 15.0% | -14.9% | |
| Return on equity | 10.8% | 9.7% | 9.6% | 12.7% | -12.8% | |
| Return on invested capital | 9.1% | 8.3% | 8.3% | 3.9% | -4.9% | |
| Return on capital employed | 12.6% | 11.3% | 12.1% | 4.0% | -6.2% | |
| Earnings yield | 5.8% | 4.6% | 5.1% | 13.6% | -12.3% | |
| Free cash flow yield | 9.3% | 7.9% | 7.4% | 1.7% | -4.0% | |
| Capex / Op. cash flow | 13.0% | 11.1% | 13.0% | 58.5% | 191.2% | |
| Capex / Depreciation | 109.4% | 77.4% | 76.0% | 105.7% | 145.8% | |
| Capex / Sales | 2.7% | 2.3% | 2.5% | 2.8% | 10.7% | |
| SG&A / Sales | 36.4% | 35.7% | 35.6% | 40.2% | 45.0% | |
| R&D / Sales | 8.7% | 8.4% | 7.6% | 10.1% | 12.6% | |
| Stock comp / Sales | 3.6% | 3.6% | 2.9% | 2.8% | 5.1% | |
| Intangibles / Total assets | 48.1% | 45.7% | 43.6% | 40.6% | 40.0% | |
| Days sales outstanding | 59d | 58d | 61d | 73d | 69d | |
| Days payables outstanding | 49d | 72d | 38d | 36d | 27d | |
| Operating cycle | 59d | 58d | 61d | 115d | 103d | |
| Cash conversion cycle | 10d | -14d | 23d | 79d | 76d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
Peer market caps
Recent news
- 2026-08-06 Spok-Powered Hospitals Recognized on 2026-2027 U.S. News & World Report''s Best Hospitals Honor Roll PLANO, Texas--(BUSINESS WIRE)--Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a global leader in healthcare communications, today reported that 18 of the 20 adult hospitals featured on the 2026-2027 U.S. News & World Report Best Hospitals Honor Roll use Spok technology to enhance care coordination and support exceptional patient care. For over a decade, the majority of Honor Roll hospitals have consistently leveraged Spok solutions to streamline workflows an.
- 2026-07-29 Spok Q2 Earnings Call Highlights Spok NASDAQ: SPOK reported second-quarter 2026 results marked by higher software bookings, record adjusted EBITDA and continued capital returns to stockholders, while management modestly lowered its full-year revenue outlook amid longer customer sales cycles and demand for shorter contract terms.
- 2026-07-29 Spok Holdings, Inc. (SPOK) Q2 2026 Earnings Call Transcript Spok Holdings, Inc. (SPOK) Q2 2026 Earnings Call Transcript
- 2026-07-29 Spok Holdings (SPOK) Q2 Earnings and Revenues Surpass Estimates Spok Holdings (SPOK) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.22 per share a year ago.
- 2026-07-29 Spok Reports Second Quarter 2026 Results PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced results for the second quarter ended June 30, 2026. In addition, the Company''s Board of Directors declared a regular quarterly dividend of $0.3125 per share, payable on September 9, 2026, to stockholders of record on August 19, 2026. Recent Highlights: Adjusted EBITDA totaled $9.1 million in the second quarter of 2026, up 22.1% from the prior year period. Second-quart.
- 2026-06-24 Spok Announces Sale of Spectrum Licenses to Sensus PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced the entry into an agreement to sell certain narrowband spectrum licenses in its two-way paging inventory to Sensus USA, a designer and manufacturer of metering and automatic meter-reading products catering to municipal and industrial markets worldwide. The purchase price is $8 million, with a portion of the consideration deferred until existing Spok users have been mi.